Loading clinical trials...
Loading clinical trials...
Pilot Study to Evaluate the Efficacy and Safety of Xvie (Human Amniotic Fluid Derived Nanoparticle Solution) Delivered Into the Scalp by Microneedling in Women With Self-perceived Thinning Hair
Conditions
Interventions
XVIE
Locations
2
United States
Advanced Dermatology & Cosmetic Surgery
Maitland, Florida, United States
Kindred Hair & Skin Center
Marriottsville, Maryland, United States
Start Date
September 29, 2025
Primary Completion Date
March 1, 2026
Completion Date
June 1, 2026
Last Updated
November 6, 2025
Lead Sponsor
Restore Biologics Holdings, Inc. dba Xtressé
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions